Allinky is a company dedicated to the discovery and development of novel therapeutic agents that block the biochemical signals driving cancer and inflammation. Following Nature's own strategy to block the excess activation of molecular signals, our “allosteric” small molecules switch off the signals responsible for disease onset and progression.